Literature DB >> 1616861

MRI screening of kindred at risk of developing paragangliomas: support for genomic imprinting in hereditary glomus tumours.

A P van Gils1, A G van der Mey, R P Hoogma, L A Sandkuijl, P D Maaswinkel-Mooy, T H Falke, E K Pauwels.   

Abstract

Paragangliomas of the head and neck (glomus tumours) can occur in a hereditary pattern and may be hormonally active as well as being associated with paragangliomas elsewhere. A number of these tumours may be present without symptoms. To detect the presence of subclinical paragangliomas we screened 83 members of a family at risk of developing hereditary paragangliomas using whole body MRI and urinary catecholamine testing. In eight previously diagnosed members, eight known glomus tumours of which one functioning, and two unknown glomus tumours and one unknown pheochromocytoma were present. Six unsuspected members showed ten glomus tumours and one pheochromocytoma. It has been suggested that the manifestation of hereditary glomus tumours is determined by the sex of the transmitting parent. There were no tumours in the descendants of female gene carriers. Comparing the likelihood of inheritance with genomic imprinting versus inheritance without genomic imprinting we found an odds ratio of 23375 in favour of genomic imprinting.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616861      PMCID: PMC1977751          DOI: 10.1038/bjc.1992.189

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

Review 1.  Genomic imprinting: review and relevance to human diseases.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

2.  Paragangliomas of the jugular bulb and carotid body: MR imaging with short sequences and Gd-DTPA enhancement.

Authors:  T Vogl; R Brüning; H Schedel; K Kang; G Grevers; D Hahn; J Lissner
Journal:  AJR Am J Roentgenol       Date:  1989-09       Impact factor: 3.959

Review 3.  Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory.

Authors:  A G van der Mey; P D Maaswinkel-Mooy; C J Cornelisse; P H Schmidt; J J van de Kamp
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

4.  MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.

Authors:  A P van Gils; T H Falke; A R van Erkel; J W Arndt; M P Sandler; A G van der Mey; R P Hoogma
Journal:  Radiographics       Date:  1991-01       Impact factor: 5.333

5.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

6.  Iodine-123-metaiodobenzylguanidine scintigraphy in patients with chemodectomas of the head and neck region.

Authors:  A P van Gils; A G van der Mey; R P Hoogma; T H Falke; A J Moolenaar; E K Pauwels; M J van Kroonenburgh
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

7.  [Various combinations of tumor-like hyperplasias of the nervous system. A contribution to the pathogenesis of systemic hyperplasia based on an autopsy as an example].

Authors:  H J LOEBLICH; A BAUMANN
Journal:  Zentralbl Allg Pathol       Date:  1960-09-15

Review 8.  Familial carotid body tumors: case report and epidemiologic review.

Authors:  S Grufferman; M W Gillman; L R Pasternak; C L Peterson; W G Young
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

Review 9.  A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience.

Authors:  P P Stein; H R Black
Journal:  Medicine (Baltimore)       Date:  1991-01       Impact factor: 1.889

10.  Functioning middle mediastinal paraganglioma (phaeochromocytoma) associated with intercarotid paragangliomas.

Authors:  G D Dunn; M J Brown; R N Sapsford; A O Mansfield; A P Hemingway; P S Sever; D J Allison
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

View more
  6 in total

Review 1.  Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities.

Authors:  A P van Gils; A R van Erkel; T H Falke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1994-03

2.  Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands.

Authors:  E M van Schothorst; J C Jansen; E Grooters; D E Prins; J J Wiersinga; A G van der Mey; G J van Ommen; P Devilee; C J Cornelisse
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

3.  Laryngeal paraganglioma: a rare clinical entity managed by supraselective embolization and lateral pharygotomy.

Authors:  Sudhir M Naik; Ashok M Shenoy; Purshottam Chavan; Akkamahadevi Patil; Sumit Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-10-06

4.  The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.

Authors:  Erik F Hensen; Jeroen C Jansen; Maaike D Siemers; Jan C Oosterwijk; Annette Hjt Vriends; Eleonora Pm Corssmit; Jean-Pierre Bayley; Andel Gl van der Mey; Cees J Cornelisse; Peter Devilee
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

5.  First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).

Authors:  J C Oosterwijk; J C Jansen; E M van Schothorst; A W Oosterhof; P Devilee; E Bakker; M W Zoeteweij; A G van der Mey
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

6.  A Study of Paraganglioma Cases With Non-European Ancestry.

Authors:  Sadia Ejaz; Neeharika Nandam; Susan Maygarden; Maya Styner
Journal:  Cureus       Date:  2022-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.